The FDA has approved Valtoco (diazepam nasal spray; Neurelis) for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epilepsy 6 years of age and older.
Taro Pharmaceuticals announced the voluntary recall of 1 lot of lamotrigine 100mg tablets to the consumer level due to cross-contamination with a small amount of enalapril maleate.
Researchers established a prediction model based on the additive effect of 4 independent factors that form an accurate model for predicting the risk of drug-resistant epilepsy in children with cerebral palsy.
Among infants breastfed by mothers who are receiving drug therapy for epilepsy, antiepileptic drug (AED) concentrations in infant blood samples are substantially lower than those in maternal blood samples.
This study described data collected from patients who self-selected to participate in the Cleveland Clinic Epilepsy Center’s virtual follow-up program.
Researchers find qEG may provide adequate reassurance that an asymptomatic infant with a normal qEEG will not develop SWS.
The My Seizure Gauge project reports significant progress in gathering data for the development and validation of a noninvasive, wearable biosensor system for forecasting seizures.
Compared to nonhormonal contraception, hormonal contraception appears to pose a greater risk for increased seizure frequency in women with epilepsy.
Poor seizure control, lack of breastfeeding education from a neurologist or lactation consultant, are factors contributing to lower breastfeeding rates in women with epilepsy, compared with the general population.
Children who suffer from infantile spasms (IS) may be at increased risk for developing autism spectrum disorder (ASD), but very few of their siblings are at risk for epilepsy or ASD, according to study results presented at the American Epilepsy Society 2019 Annual Meeting, held in Baltimore, Maryland from December 6 to 10. Previous studies…
